SWS
GILD icon

SYSTM Wealth Solutions’s Gilead Sciences GILD Stock Holding History

SYSTM Wealth Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,852
Closed -$127K – 306
2024
Q2 		$127K Sell
1,852
-336
-15% -$22.4K 0.03% 230
2024
Q1 		$160K Buy
2,188
+50
+2% +$3.85K 0.02% 422
2023
Q4 		$173K Sell
2,138
-743
-26% -$57.8K 0.02% 397
2023
Q3 		$216K Buy
+2,881
New +$222K 0.03% 424
2023
Q1 		– Sell
-13,446
Closed -$1.15M – 489
2022
Q4 		$1.15M Buy
+13,446
New +$1.06M 0.14% 187

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SYSTM Wealth Solutions's GILD Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 1,852 shares — an estimated $127K sold.

SYSTM Wealth Solutions first reported a position in GILD in Q4 2022 and held it in 5 quarters. The position peaked at $1.15M in Q4 2022. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 1,852 Gilead Sciences shares in Q3 2024, an estimated $127K.
  • SYSTM Wealth Solutions first reported a position in Gilead Sciences in Q4 2022 and held it in 5 quarters.
  • SYSTM Wealth Solutions's Gilead Sciences position peaked at $1.15M in Q4 2022.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.